Johanna Chiffelle
Lausanne Branch
Lausanne, VD, Switzerland
Lausanne, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Harnessing TCR repertoires: predictive insights and therapeutic monitoring in cancer immunotherapy.
Journal: Immuno-oncology technology
Published: November 17, 2025
Author Correction: Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms.
Journal: Nature biotechnology
Published: June 25, 2024
Personalized cancer T-cell therapy takes the stage, mirroring vaccine success.
Journal: The Journal of experimental medicine
Published: June 11, 2024
Predicting Antigen-Specificities of Orphan T Cell Receptors from Cancer Patients with TCRpcDist.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 30, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma.
Journal: Science immunology
Published: February 02, 2024
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy.
Journal: Nature biotechnology
Published: December 04, 2023
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma.
Journal: Immunity
Published: August 18, 2023
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function.
Journal: Nature
Published: May 22, 2023
Machine learning methods and harmonized datasets improve immunogenic neoantigen prediction.
Journal: Immunity
Published: March 27, 2023
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs.
Journal: Cell reports methods
Published: October 17, 2022
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors.
Journal: Nature communications
Published: June 21, 2022
Last Updated: 09/26/2026